These figures pool every individual call made by BMO Capital's analysts into a single sample — so a prolific analyst carries more weight than a low-volume one, exactly in proportion to the evidence available. All metrics are computed independently by 13Foresight from historical prices. Returns are measured in each stock's own trading currency, so for non-US listings the comparison against the S&P 500 does not account for currency moves — a US investor's dollar return would differ by however the exchange rate shifted.
| Analyst | Our Rank | Stars | Success | Avg Return | vs S&P | Calls |
|---|---|---|---|---|---|---|
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Pro analyst | — | — | — | — | — | — |
| Michael Goldie | #402 | ★★★★ | 67% | +9.7% | +6.5% | 21 |
| Tom Mackinnon | #431 | ★★★★ | 70% | +8.5% | +1.3% | 27 |
| Evan Seigerman | #468 | ★★★★ | 68% | +4.5% | +0.4% | 103 |
| Keith Bachman | #470 | ★★★★ | 64% | +8.7% | +3.4% | 89 |
| Daniel Jester | #493 | ★★★★ | 65% | +9.6% | +4.6% | 46 |
| Jeffrey Silber | #607 | ★★★★ | 62% | +8.3% | +3.2% | 73 |
| Charlie Lederer | #737 | ★★★★ | 73% | +10.9% | -0.9% | 11 |
| Tom Callaghan | #761 | ★★★★ | 68% | +5.1% | -4.9% | 40 |
| Jack Matten | #856 | ★★★★ | 64% | +12.8% | +0.5% | 14 |
| Tim Casey | #922 | ★★★★ | 67% | +2.6% | -4.2% | 24 |
| Sohrab Movahedi | #936 | ★★★★ | 67% | +8.8% | -2.7% | 12 |
| Vik Chopra | #949 | ★★★ | 59% | +4.6% | -0.5% | 46 |
| John McNulty | #957 | ★★★ | 58% | +4.2% | +0.1% | 73 |
| Tristan M. Thomas-Martin | #968 | ★★★ | 62% | +1.6% | -2.8% | 29 |
| Kelly Bania | #1049 | ★★★ | 59% | +3.7% | -1.4% | 34 |
| Andrew Bauch | #1059 | ★★★ | 63% | +5.5% | -4.8% | 46 |
| Etienne Ricard | #1119 | ★★★ | 59% | +5.4% | -2.3% | 44 |
| Sean Dodge | #1139 | ★★★ | 65% | +6.3% | +0.9% | 48 |
| Fadi Chamoun | #1188 | ★★★ | 64% | +4.4% | -0.1% | 55 |
| Katja Jancic | #1225 | ★★★ | 61% | +1.0% | -4.8% | 33 |
| Ari Klein | #1318 | ★★★ | 54% | +2.7% | -1.7% | 41 |
| Daniel DiCicco | #1327 | ★★★ | 65% | -1.4% | -4.3% | 31 |
| Benjamin Pham | #1454 | ★★★ | 51% | +2.3% | -1.6% | 51 |
| Raj Ray | #1458 | ★★★ | 52% | +18.1% | +10.9% | 42 |
| Brian Pitz | #1472 | ★★★ | 51% | +5.0% | +0.5% | 70 |
| Thanos Moschopoulos | #1503 | ★★★ | 59% | +0.3% | -6.2% | 32 |
| Kevin O'Halloran | #1507 | ★★★ | 54% | +2.2% | -2.5% | 35 |
| Alexander Pearce | #1644 | ★★★ | 53% | +12.5% | -2.1% | 32 |
| Stephen Macleod | #1707 | ★★★ | 47% | +16.0% | +10.0% | 34 |
| Michael Markidis | #1740 | ★★★ | 69% | +2.2% | -14.5% | 36 |
| James Thalacker | #1859 | ★★★ | 47% | +0.0% | -2.4% | 96 |
| Jeremy Mccrea | #1862 | ★★★ | 52% | +3.5% | -6.2% | 33 |
| Devin Dodge | #1904 | ★★★ | 44% | +1.1% | -1.9% | 41 |
| Phillip Jungwirth | #1912 | ★★★ | 52% | +1.9% | -5.5% | 69 |
| Bhavesh Lodaya | #1913 | ★★★ | 50% | -1.4% | -6.6% | 22 |
| Ameet Thakkar | #1988 | ★★★ | 49% | +0.1% | -3.2% | 53 |
| John Gibson CFA | #2024 | ★★★ | 45% | +1.6% | -3.7% | 38 |
| Eric Borden | #2075 | ★★★ | 43% | -2.8% | -6.6% | 14 |
| Ryan Griffin CFA | #2265 | ★★ | 25% | -3.2% | -8.2% | 8 |
| Randy Ollenberger | #2467 | ★★ | 53% | +12.2% | +0.0% | 72 |
| Andrew Mikitchook | #2484 | ★★ | 47% | +3.6% | -13.7% | 19 |
| Brian Quast | #2539 | ★★ | 50% | -0.1% | -11.0% | 32 |
| Joel Jackson | #2676 | ★★ | 38% | -0.3% | -8.9% | 34 |
| Andrew Strelzik | #2783 | ★★ | 41% | -1.8% | -8.0% | 56 |
| Rene Cartier | #2838 | ★ | 41% | -7.5% | -15.0% | 27 |
| Tariq Saad | — | — | 43% | +4.0% | -5.2% | 7 |
| Benjamin Mayhew | — | — | 40% | +9.9% | +4.3% | 5 |
The 6 top-ranked analysts at BMO Capital, the firm's full 3- and 5-year track record, and firm-vs-firm rankings across Wall Street. Everything below the top 6, plus 1- and 2-year history, stays free — Pro is what keeps this independent research running and the servers paid for.
Upgrade to ProDisclaimer: Firm-level performance is calculated independently by 13Foresight by pooling the historical calls of analysts associated with this firm, measured against market prices. It may be incomplete or delayed, is for research purposes only, and is not investment advice.